DXO: Transducer, Pressure, Catheter Tip
What it covers
A catheter tip pressure transducer is a device incorporated into the distal end of a catheter. When placed in the bloodstream, its mechanical or electrical properties change in relation to changes in blood pressure. These changes are transmitted to accessory equipment for processing.
The identification in 21 CFR 870.2870, catheter tip pressure transducer. FDA gives DXO no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K251367 | OptoMonitor 3 | Opsens, Inc. | Jan 16, 2026 | Traditional |
| K241418 | OptoMonitor 3 | Opsens, Inc. | Feb 12, 2025 | Traditional |
| K233904 | ACIST RXi System (016616); ACIST Navvus II Catheter (016675_ | Acist Medical Systems, Inc. | Jul 17, 2024 | Traditional |
| K222216 | TruWave Disposable Pressure Transducer | Edwards Lifesciences, LLC | Dec 22, 2022 | Traditional |
| K202943 | OptoMonitor 3 | Opsens, Inc. | Nov 24, 2020 | Traditional |
| K193620 | OptoMonitor 3 | Opsens, Inc. | Jun 18, 2020 | Traditional |
| K193279 | Comet II Pressure Guidewire | Boston Scientific Corporation | Dec 23, 2019 | Special |
| K192340 | OptoMonitor | Opsens, Inc. | Dec 12, 2019 | Traditional |
| K190852 | Zurich Pressure Guidewire System Model 100 | Zurich Medical, Inc. | Aug 14, 2019 | Traditional |
| K183413 | TruWave Disposable Pressure Transducer | Edwards Lifeciences, LLC | May 1, 2019 | Traditional |
Clearances by year
23 DXO 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 260 |
| 2025 | 1 | 268 |
| 2024 | 1 | 219 |
| 2022 | 1 | 150 |
| 2020 | 2 | 115 |
| 2019 | 4 | 120 |
| 2018 | 1 | 27 |
| 2017 | 2 | 106 |
| 2016 | 2 | 121 |
| 2015 | 2 | 115 |
| 2014 | 3 | 176 |
| 2013 | 1 | 108 |
| 2012 | 1 | 88 |
| 2011 | 1 | 67 |
Who submits
13 applicants cleared a DXO device since 2011. 70% of the clearances went to applicants in United States, then Canada (26%) and Sweden (4%). By type: Traditional 87% and Special 13%. 1 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Opsens, Inc. | 6 |
| Edwards Lifesciences, LLC | 4 |
| Boston Scientific Corporation | 2 |
| St. Jude Medical Systems AB | 2 |
| Acist Medical Systems | 1 |
| Acist Medical Systems, Inc. | 1 |
| Edwards Lifeciences, LLC | 1 |
| Millar Instruments, Inc. | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.2870.
Standards
21 CFR 870.2870 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DXO clearances declared.
Ask about DXO
Questions about DXO
What is FDA product code DXO?
Product code DXO, “Transducer, Pressure, Catheter Tip” in FDA's classification database, is a Class II device type under 21 CFR 870.2870 (catheter tip pressure transducer), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 64 clearances under DXO, 23 of them since 2011.
How many 510(k) clearances are there under DXO?
FDA’s 510(k) database listed 64 clearances under DXO as of Oct 29, 2026, 23 of them decided since 2011; the most recent decision was Jan 16, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DXO 510(k)?
For the 2 DXO clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 264 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DXO clearances?
Since 2011: Opsens, Inc. (6), Edwards Lifesciences, LLC (4), Boston Scientific Corporation (2), St. Jude Medical Systems AB (2) and Acist Medical Systems (1). 13 applicants have cleared a DXO device in that time.